Status | Study |
Completed |
Study Name: Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis Condition: IGA Glomerulonephritis Date: 2010-04-28 Interventions: Drug: Ramipril or losartan Ramipril (5 mg/day) was started soon after the enrollment and continued throu |
Completed |
Study Name: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy Condition: Glomerulonephritis Date: 2010-03-24 Interventions: Drug: Adrenocorticotrophic hormone ACTH There will be two arms to the study: one arm receive 40 units an |
Completed |
Study Name: Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy Condition: Chronic Glomerulonephritis Diabetic Nephropathy Date: 2009-06-03 Interventions: Drug: olmesartan medoxomil olmesartan medoxomil tablets, once daily |
Active, not recruiting |
Study Name: Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG) Condition: Glomerulonephritis, Membranous Date: 2009-02-12 Interventions: Drug: tacrolimus tacrolimus 2m |
Completed |
Study Name: Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy Condition: Glomerulonephritis, IGA Date: 2007-08-27 Interventions: Procedure: gene transcription and cytometry samply of 30 ml of blood |
Completed |
Study Name: Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor Condition: Glomerulonephritis Date: 2007-02-20 Interventions: Drug: Ramipril 2.5mg and increase to 5mg if patient do not develop symptomatic hypotension |
Completed |
Study Name: ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT Condition: Glomerulonephritis, IGA Date: 2006-09-19 Interventions: Drug: prednisone + Inhibace/Cozaar Drug: I |
Terminated |
Study Name: Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis Condition: Glomerulonephritis Date: 2006-07-18 Interventions: Drug: pentoxifylline intraveno |
Completed |
Study Name: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis Condition: ADPKD Glomerulonephritis Date: 2006-06-24 Interventions: Drug: Ng-monomethyl-L-arginine (drug) |
Completed |
Study Name: Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis Condition: Glomerulonephritis, Membranoproliferative Date: 2006-01-10 Interventions: Drug: Rituximab The Rituximab dose is 1000 mg (1 gm) given as an IV infusion every two weeks for 2 doses |